Claim CME

Vaccination

Comparing Human Milk Antibody Response After 4 Different Vaccines for COVID-19

Educational Objective
To identify the key insights or developments described in this article

1 Credit CME

JAMA Pediatrics

June 1, 2022

Research Letter

Article Information and Disclosures

Hannah G. Juncker, MD¹;

Sien J. Mulleners, BSc¹;

Esmée R. M. Coenen, BSc¹;

et al

Johannes B. van Goudoever, MD, PhD¹;

Marit J. van Gils, PhD²;

Britt J. van Keulen, MD¹

Author Affiliations

¹Amsterdam Reproduction & Development Research Institute, Department of Pediatrics, Emma Children’s Hospital, Amsterdam UMC, Amsterdam, the Netherlands
²Amsterdam Infection and Immunity Institute, Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands

Read article on JAMA Network

Read Article Claim CME

COVID-19 usually has a mild course in children; however, newborns and infants are more susceptible to severe disease.¹ Human milk is suggested to play an important role to protect against infections, mostly owing to disease-specific antibodies.² Antibodies against SARS-CoV-2 are present in the human milk of previously infected women,³ as well as following vaccination with a SARS-CoV-2 vaccine,⁴ and are capable of neutralizing the virus. Because maternal vaccination during lactation may protect not only the mother but also her breastfed infant, knowledge of its effect is important to guide health care workers and lactating women in decision-making regarding SARS-CoV-2 vaccination. Therefore, this study aims to compare the antibody response in human milk after vaccination with mRNA-based and vector-based vaccines.

Claim CME

Buy This Activity

Article Information

Accepted for Publication: January 5, 2022.

Published Online: March 14, 2022. doi:10.1001/jamapediatrics.2022.0084

Corresponding Author: Johannes B. van Goudoever, MD, PhD, Emma Children’s Hospital, Amsterdam UMC, Meibergdreef 9, 1000 DE, Amsterdam, the Netherlands (h.vangoudoever@amsterdamumc.nl).

Author Contributions: Drs van Goudoever and van Keulen had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Juncker, Mulleners, Coenen, van Goudoever, van Keulen.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Juncker, Mulleners, Coenen, van Goudoever, van Keulen.

Critical revision of the manuscript for important intellectual content: van Goudoever, van Gils, van Keulen.

Statistical analysis: Juncker, Mulleners, Coenen, van Keulen.

Obtained funding: van Goudoever, van Keulen.

Administrative, technical, or material support: All authors.

Supervision: van Goudoever, van Keulen.

Conflict of Interest Disclosures: Dr van Goudoever reported grants from the Support Foundation Emma Children's Hospital during the conduct of the study, as well as being founder and director of the Dutch National Human Milk Bank, and a member of the Health Council. No other disclosures were reported.

Funding/Support: This research was funded by Stichting Steun Emma Kinderziekenhuis and the Amsterdam Infection and Immunity Institute (COVID-19 grant 24175).

Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Additional Contributions: We thank all participating mothers, students, and research assistants for helping with this study. Participants were not compensated for their contributions.

References

Götzinger F , Santiago-García B , Noguera-Julián A , et al; ptbnet COVID-19 Study Group. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4(9):653-661. doi:10.1016/S2352-4642(20)30177-2 PubMed Google Scholar Crossref

Hanson LA . Session 1: Feeding and infant development breast-feeding and immune function. Proc Nutr Soc. 2007;66(3):384-396. doi:10.1017/S0029665107005654 PubMed Google Scholar Crossref

van Keulen BJ , Romijn M , Bondt A , et al. Human milk from previously COVID-19-infected mothers: the effect of pasteurization on specific antibodies and neutralization capacity. Nutrients. 2021;13(5):1645. doi:10.3390/nu13051645 PubMed Google Scholar Crossref

Perl SH , Uzan-Yulzari A , Klainer H , et al. SARS-CoV-2-specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. JAMA. 2021;325(19):2013-2014. doi:10.1001/jama.2021.5782 PubMed Google Scholar Crossref

Atyeo C , Alter G . The multifaceted roles of breast milk antibodies. Cell. 2021;184(6):1486-1499. doi:10.1016/j.cell.2021.02.031 PubMed Google Scholar Crossref

Comparing Human Milk Antibody Response After 4 Different Vaccines for COVID-19

See More About

Want full access to the AMA Ed Hub?

AMA Membership provides:

Sign in to access

Want full access to the AMA Ed Hub?

Sign in to customize your interests

With a personal account, you can:

Name Your Search

Sign in to save your search

With a personal account, you can:

Lookup An Activity

My Saved Searches

My Saved Courses

Sign in to customize your interests

With a personal account, you can:

Purchase access